NCT01789788View on ClinicalTrials.gov

A Safety, Pharmacokinetics and Pharmacodynamics Study of RO6811135 in Patients With Type 2 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Diabetes Mellitus Type 2
Interventions
DRUG

Placebo

Matching placebo, multiple doses

DRUG

RO6811135

multiple ascending doses

Trial Locations (2)

45227

Cincinnati

91911

Chula Vista

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01789788 - A Safety, Pharmacokinetics and Pharmacodynamics Study of RO6811135 in Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter